Heart Disease News and Research

Latest Heart Disease News and Research

Cognitive impairments linked to mood episode recurrence risk

Cognitive impairments are associated with an increased risk for mood episode recurrence in euthymic patients with bipolar disorder, researchers report.

11 Dec 2012

CYP2J2 implicated in preeclampsia

Study findings suggest that uteroplacental cytochrome P450 subfamily 2J polypeptide 2 overexpression contributes to preeclampsia.

11 Dec 2012

Telestroke networks benefit hospital bank balances

Telestroke networks can increase the number of patients successfully discharged home while saving money for all hospitals involved, show US study results.

11 Dec 2012

Depression treatment ‘should target emotional control’

Being able to regulate emotions is a key driver of patients’ improvement in symptoms when undergoing treatment for depression, German researchers have shown.

11 Dec 2012

Chest-compression-only CPR ‘should be standard’ for bystander resuscitation

Cardiopulmonary resuscitation with chest compressions only seems to be the most effective form of resuscitation when delivered by lay bystanders along with public-access automated external defibrillation, research suggests.

11 Dec 2012

Studies examine current treatment standards for patients with clotting disorders

Studies presented today at the 54th Annual Meeting of the American Society of Hematology (ASH) examine current treatment standards for patients with clotting disorders in an effort to improve outcomes.

11 Dec 2012

Cedars-Sinai first in Los Angeles County to achieve Comprehensive Stroke Center Certification

Cedars-Sinai is one of the first five medical centers in the nation and the first in Los Angeles County to achieve Comprehensive Stroke Center Certification from The Joint Commission and the American Heart Association/American Stroke Association.

11 Dec 2012

AMAG presents new data from two ferumoxytol phase III trials on IDA at ASH annual meeting

AMAG Pharmaceuticals, Inc. today announced that new data from two pivotal phase III clinical trials were presented at the American Society of Hematology's (ASH) annual meeting in Atlanta, Georgia.

11 Dec 2012

Merrimack announces results from MM-302 Phase I trial on advanced HER2 positive breast cancer

Merrimack Pharmaceuticals, Inc. today announced Phase I clinical trial results for MM-302, the company's novel agent for the treatment of advanced HER2 positive (HER2+ or ErbB2+) breast cancer.

11 Dec 2012

Alpha arrestins may play a role in cell signaling that is crucial to new drug development

A newly found understanding of receptor signaling may have revealed a better way to design drugs. A study from Nationwide Children's Hospital suggests that a newly identified group of proteins, alpha arrestins, may play a role in cell signaling that is crucial to new drug development.

11 Dec 2012

Janssen receives FDA approval for ZYTIGA to treat metastatic castration-resistant prostate cancer

Janssen announced today that the U.S. Food and Drug Administration (FDA) has approved a broader indication for the oral, once-daily medication ZYTIGA (abiraterone acetate).

10 Dec 2012

Childhood obesity: an interview with Professor Clodagh O’Gorman

Childhood obesity is harder to define than adult obesity. This is because any definition of obesity relies on measurements of both height and weight, and the calculation of body mass index (BMI) based on these measurements.

10 Dec 2012

CYP2J2 implicated in preeclampsia

Study findings suggest that uteroplacental cytochrome P450 subfamily 2J polypeptide 2 overexpression contributes to preeclampsia.

10 Dec 2012

Heart-healthy diet may reduce recurrent stroke, MI risk

Eating a “heart-healthy” diet may lower the risk for recurrent cardiovascular disease events in middle-aged individuals with a history of such conditions, researchers report.

10 Dec 2012

Tips to prevent ‘holiday heart’ syndrome

The holiday season is supposed to be joyous, fun and happy. But it can also be stressful. The nation's emergency physicians want to remind all Americans to keep your stress in check.

10 Dec 2012

Amgen signs definitive agreement to acquire deCODE Genetics

Amgen and deCODE Genetics today announced that the companies have entered into a definitive agreement under which Amgen will acquire deCODE Genetics, a global leader in human genetics, headquartered in Reykjavik, Iceland.

10 Dec 2012

Communication and checklists may lead to fewer surgical complications

An article published in the December issue of the Journal of the American College of Surgery found decreases in some postoperative complications when surgical teams were trained in communication and to use a procedure check list.

10 Dec 2012

Roundup: Texas Medicaid funding fight looms; Minn. facing federal Medicaid scrutiny; health care jobs 'boom'

If the Texas Legislature is in session, there must be a fight about Medicaid going on. The health care program for the disabled, the elderly poor and the impoverished raises hackles every two years, mostly because the number in need keeps rising alongside health care costs.

10 Dec 2012

First Edition: December 10, 2012

Today's headlines include news about yesterday's "fiscal cliff" meeting between President Barack Obama and House Speaker John Boehner, as well as other health policy reports.

10 Dec 2012

New survival results from Genentech’s Perjeta Phase III combination study on HER2-positive mBC

Genentech, a member of the Roche Group, today announced updated survival results from the Phase III CLEOPATRA study, which showed that the combination of Perjeta (pertuzumab), Herceptin (trastuzumab) and docetaxel chemotherapy significantly extended the lives (overall survival) of people with previously untreated HER2-positive metastatic breast cancer (mBC), compared to Herceptin, chemotherapy and placebo.

10 Dec 2012

Heart Disease News and Research

Latest Heart Disease News and Research

Cognitive impairments linked to mood episode recurrence risk

CYP2J2 implicated in preeclampsia

Telestroke networks benefit hospital bank balances

Depression treatment ‘should target emotional control’

Chest-compression-only CPR ‘should be standard’ for bystander resuscitation

Studies examine current treatment standards for patients with clotting disorders

Cedars-Sinai first in Los Angeles County to achieve Comprehensive Stroke Center Certification

AMAG presents new data from two ferumoxytol phase III trials on IDA at ASH annual meeting

Merrimack announces results from MM-302 Phase I trial on advanced HER2 positive breast cancer

Alpha arrestins may play a role in cell signaling that is crucial to new drug development

Janssen receives FDA approval for ZYTIGA to treat metastatic castration-resistant prostate cancer

Childhood obesity: an interview with Professor Clodagh O’Gorman

CYP2J2 implicated in preeclampsia

Heart-healthy diet may reduce recurrent stroke, MI risk

Tips to prevent ‘holiday heart’ syndrome

Amgen signs definitive agreement to acquire deCODE Genetics

Communication and checklists may lead to fewer surgical complications

Roundup: Texas Medicaid funding fight looms; Minn. facing federal Medicaid scrutiny; health care jobs 'boom'

First Edition: December 10, 2012

New survival results from Genentech’s Perjeta Phase III combination study on HER2-positive mBC

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Heart Disease News and Research

Latest Heart Disease News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in